Clinical Trials

    A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD) (REGENERATE-PD)

    Investigator: William Ondo

    Study Coordinator: Daniel Arnaud Dominguez

    Status: Enrolling

    ClinicalTrials.gov Number: NCT06285643

    Phone: 346.356.3635

    Protocol Number: PRO00038075

    Description


    The objective of this randomized, surgically controlled, double-blinded, Phase 2 study is to evaluate the safety and efficacy of AAV2-GDNF delivered to the putamen in subjects with moderate Parkinson's Disease.